NCT01941446View on ClinicalTrials.gov

A Thorough QT/QTc Study to Evaluate the Effects of an Intravenous Infusion of Eravacycline (TP-434) on Cardiac Repolarization

PHASE1CompletedINTERVENTIONAL
Enrollment

54

Participants

Timeline

Start Date

March 31, 2013

Primary Completion Date

June 30, 2013

Study Completion Date

July 31, 2013

Conditions
Normal Healthy Subjects
Interventions
DRUG

Eravacyline, Moxifloxacin, and placebo

All Listed Sponsors
lead

Tetraphase Pharmaceuticals, Inc

INDUSTRY

NCT01941446 - A Thorough QT/QTc Study to Evaluate the Effects of an Intravenous Infusion of Eravacycline (TP-434) on Cardiac Repolarization | Biotech Hunter | Biotech Hunter